Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer

Details for Australian Patent Application No. 2007334039 (hide)

Owner Eli Lilly and Company

Inventors Crich, Joyce Z.; Henry, James Robert; Slater, Melissa Kate; Brooks, Harold Burns; Wang, Yan; Li, Hong-Yu

Agent Spruson & Ferguson

Pub. Number AU-B-2007334039

PCT Pub. Number WO2008/076704

Priority 60/871,302 21.12.06 US

Filing date 11 December 2007

Wipo publication date 26 June 2008

Acceptance publication date 16 February 2012

International Classifications

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/076704 Priority application(s): WO2008/076704

16 February 2012 Application Accepted

  Published as AU-B-2007334039

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334040-Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer

2007334038-Methods and compositions for treating gastrointestinal disorders